Timothy P Lund, MD | |
3151 E Center Street Ext, Warsaw, IN 46582-3901 | |
(574) 267-3070 | |
(574) 267-4813 |
Full Name | Timothy P Lund |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 3151 E Center Street Ext, Warsaw, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265475701 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 01043652 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Timothy P Lund, MD 50870 Coventry Ct, Elkhart, IN 46514-6078 Ph: (309) 230-6837 | Timothy P Lund, MD 3151 E Center Street Ext, Warsaw, IN 46582-3901 Ph: (574) 267-3070 |
News Archive
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
Human cells divide and create new cells throughout life. In this process, a steady – even rhythmic – supply of DNA building blocks is needed to create new DNA. Now researchers from the University of Copenhagen are the first to show exactly how human cells regulate this process so it does not fail and cause illness.
BBI Solutions has launched Morffi, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September.
› Verified 7 days ago